Back to search results

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

Abroad (travel likely)RecruitingPHASE2

Conditions

Focal Epilepsy · Epilepsy · Refractory Focal Epilepsy · Seizure · Focal Seizure · Focal Onset Seizure

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Consultants in Epilepsy and Neurology, PLLC, Boise, Idaho, United States

  • Mayo Clinic, Rochester, Minnesota, United States

  • NYU Langone Comprehensive Epilepsy Center, New York, New York, United States

  • Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • University of Pennsylvania - Department of Neurology, Philadelphia, Pennsylvania, United States

  • Vanderbilt University Medical Center, Nashville, Tennessee, United States

  • Baylor College of Medicine, Houston, Texas, United States

Study leads

  • Imran Quraishi, MD

    Principal Investigator

    Yale University

View source on ClinicalTrials.gov(opens in a new tab)